Published 6 days ago • loading... • Updated 5 days ago

Thermo Fisher to buy Solventum’s purification and filtration unit for $4.1B

Summary by medtechdive.com

Wall Street applauded the deal, sending shares of Solventum, the 3M spinoff, up 10% on Tuesday.

10 Articles

All

Left

Center

Right

Financial Post

Trian Comments on Solventum's Sale of its Purification & Filtration Business

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — Trian Fund Management, L.P. (“Trian”), which beneficially owns ~5% of Solventum Corporation (NYSE: SOLV) (“Solventum” o…

5 days ago·Canada

Read Full Article

The Hamilton Spectator

Reposted by

Guelph Mercury

Trian Comments on Solventum’s Sale of its Purification & Filtration Business

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Trian Fund Management, L.P. (“Trian”), which beneficially owns ~5% of Solventum Corporation (NYSE: SOLV) (“Solventum” or the “Company”) and is the Company’s

5 days ago·Hamilton, Canada

Read Full Article

The Business Journals

Solventum Corp. sells unit to Thermo Fisher for $4.1B

Solventum Corp., 3M’s medtech spinoff, has sold its purification and filtration business to Massachussetts-based Thermo Fisher Scientific for approximately $4.1 billion.

6 days ago·United States

Read Full Article

medtechdive.com

Thermo Fisher to buy Solventum’s purification and filtration unit for $4.1B

Wall Street applauded the deal, sending shares of Solventum, the 3M spinoff, up 10% on Tuesday.

6 days ago

Read Full Article

csimarket.com

#Trian Fund Management Weighs in on Solventums Strategic Sale: Shareholder Implications and Board Evolution

In a significant development for Solventum Corporation (NYSE: SOLV), Trian Fund Management, L.P. which holds approximately 5% of the company's shares, has publicly responded to the recent decision by Solventum to divest its Purification and Filtration business to Thermo Fisher Scientific Inc. (NYSE: TMO). As the largest active shareholder in the company, Trian's commentary underscores the importance of these strategic maneuvers and their potenti…

5 days ago

Read Full Article

Medical Device Network

Thermo Fisher strikes $4.1bn deal for Solventum’s purification and filtration unit

Thermo Fisher Scientific is buying Solventum’s purification and filtration business unit in a cash deal worth around $4.1bn.The post Thermo Fisher strikes $4.1bn deal for Solventum’s purification and filtration unit appeared first on Medical Device Network.

5 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year